[PHARMA] QoQ TTM Result on 31-Dec-2021 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
17-Feb-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
31-Dec-2021 [#4]
Profit Trend
QoQ- 114.27%
YoY- 526.25%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 3,359,675 4,567,669 4,983,690 4,815,015 4,737,880 3,230,009 2,698,649 15.71%
PBT 182,637 265,267 282,990 277,075 138,481 44,355 36,437 192.59%
Tax -58,325 -100,008 -104,757 -104,870 -58,488 -13,392 -9,755 229.06%
NP 124,312 165,259 178,233 172,205 79,993 30,963 26,682 178.69%
-
NP to SH 122,548 163,766 176,748 172,150 80,344 31,951 28,226 165.89%
-
Tax Rate 31.93% 37.70% 37.02% 37.85% 42.24% 30.19% 26.77% -
Total Cost 3,235,363 4,402,410 4,805,457 4,642,810 4,657,887 3,199,046 2,671,967 13.59%
-
Net Worth 411,327 406,087 413,947 450,411 391,428 357,275 355,919 10.11%
Dividend
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Div 90,356 108,678 121,759 121,748 58,895 36,634 23,534 144.99%
Div Payout % 73.73% 66.36% 68.89% 70.72% 73.30% 114.66% 83.38% -
Equity
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Net Worth 411,327 406,087 413,947 450,411 391,428 357,275 355,919 10.11%
NOSH 1,309,126 1,309,126 1,309,126 1,309,126 1,309,126 261,991 261,705 192.20%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 3.70% 3.62% 3.58% 3.58% 1.69% 0.96% 0.99% -
ROE 29.79% 40.33% 42.70% 38.22% 20.53% 8.94% 7.93% -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 256.47 348.69 380.45 367.74 361.91 246.81 1,031.18 -60.41%
EPS 9.36 12.50 13.49 13.15 6.14 2.44 10.79 -9.03%
DPS 6.90 8.30 9.30 9.30 4.50 2.80 9.00 -16.21%
NAPS 0.314 0.31 0.316 0.344 0.299 0.273 1.36 -62.33%
Adjusted Per Share Value based on latest NOSH - 1,309,336
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 233.11 316.92 345.79 334.08 328.73 224.11 187.24 15.71%
EPS 8.50 11.36 12.26 11.94 5.57 2.22 1.96 165.69%
DPS 6.27 7.54 8.45 8.45 4.09 2.54 1.63 145.29%
NAPS 0.2854 0.2818 0.2872 0.3125 0.2716 0.2479 0.247 10.10%
Price Multiplier on Financial Quarter End Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 -
Price 0.515 0.595 0.755 0.74 0.835 5.29 3.26 -
P/RPS 0.20 0.17 0.20 0.20 0.23 2.14 0.32 -26.87%
P/EPS 5.51 4.76 5.60 5.63 13.61 216.68 30.23 -67.81%
EY 18.17 21.01 17.87 17.77 7.35 0.46 3.31 210.86%
DY 13.40 13.95 12.32 12.57 5.39 0.53 2.76 186.44%
P/NAPS 1.64 1.92 2.39 2.15 2.79 19.38 2.40 -22.40%
Price Multiplier on Announcement Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 24/11/22 19/08/22 20/05/22 17/02/22 19/11/21 20/08/21 21/05/21 -
Price 0.55 0.595 0.72 0.76 0.845 0.925 4.03 -
P/RPS 0.21 0.17 0.19 0.21 0.23 0.37 0.39 -33.78%
P/EPS 5.88 4.76 5.34 5.78 13.77 37.89 37.37 -70.82%
EY 17.01 21.01 18.74 17.30 7.26 2.64 2.68 242.41%
DY 12.55 13.95 12.92 12.23 5.32 3.03 2.23 216.05%
P/NAPS 1.75 1.92 2.28 2.21 2.83 3.39 2.96 -29.53%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment